Bafna Pharmaceuticals Ltd (BAFNAPH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 852453, "name": "Bafna Pharma.", "stock_name": "Bafna Pharma.", "full_name": "Bafna Pharmaceuticals Ltd", "name_url": "stocks-analysis/bafna-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "273.55", "chg": "0.00", "chgp": "0.00%", "dir": 0, "prev_price": "273.55", "mcapval": "", "mcap": "Micro Cap", "scripcode": 532989, "symbol": "BAFNAPH", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE878I01022", "curr_date": "Aug 04, 03:30 PM", "curr_time": "10:18 AM", "last_traded_at": "Aug 04, 03:30 PM IST", "bse_nse_vol": "8.64 k", "exc_status": "Active", "traded_date": "Aug 04, 2026", "traded_date_str": "2026 08 04", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 278", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs278-4135532", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4135532.png", "date": "2026-08-04 10:37:35", "description": "Surging to a new 52-week high of Rs 278 on 4 Aug 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a sustained rally that has extended over 11 consecutive trading sessions." }, { "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 273.15 on Back of Strong Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs27315-4133693", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4133693.png", "date": "2026-08-03 10:36:11", "description": "Surging past its previous peaks, Bafna Pharmaceuticals Ltd reached a fresh 52-week high of Rs 273.15 on 3 Aug 2026, marking a remarkable rally of 219.59% over the past year against the Sensex’s decline of 2.38%. This milestone caps a sustained momentum phase, with the stock gaining for ten consecutive sessions and outperforming its sector by 1.59% on the day." }, { "title": "Bafna Pharmaceuticals Gains 9.31%: 6 Key Factors Driving the Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-931-6-key-factors-driving-the-rally-4131650", "imagepath": "", "date": "2026-08-01 15:02:44", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> New 52-week high at Rs.248.80</p>\n <p><strong>28 Jul:</strong> Further 52-week high at Rs.253.75</p>\n <p><strong>29 Jul:</strong> New 52-week high at Rs.258.80</p>\n <p><strong>30 Jul:</strong> 52-week high extended to Rs.263.95; valuation shifts noted</p>\n <p><strong>31 Jul:</strong> Week closes with new 52-week high at Rs.269.20</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.245.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">W..." }, { "title": "Bafna Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4131268", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_mojoScore_4131268.png", "date": "2026-08-01 10:10:04", "description": "Bafna Pharmaceuticals Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's present position as of 01 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Bafna Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4131280", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_mojoScore_4131280.png", "date": "2026-08-01 10:10:04", "description": "Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 269.2", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2692-4130240", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_priceRelatedfactors_4130240.png", "date": "2026-07-31 10:36:44", "description": "Surging to a new 52-week high of Rs 269.2 on 31 Jul 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 205.94% gain over the past year against the Sensex’s 4.00% decline." }, { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 263.95", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs26395-4128633", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_priceRelatedfactors_4128633.png", "date": "2026-07-30 10:36:13", "description": "Surging past its previous peaks, Bafna Pharmaceuticals Ltd touched a new 52-week high of Rs 263.95 on 30 Jul 2026, marking a remarkable rally of nearly 200% from its 52-week low of Rs 77.01. This milestone caps an eight-day winning streak that has propelled the stock well above all major moving averages, signalling robust price momentum and technical conviction." }, { "title": "Bafna Pharmaceuticals Ltd Valuation Shifts Amidst Strong Market Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-valuation-shifts-amidst-strong-market-performance-4127810", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_valuationdot_4127810.png", "date": "2026-07-30 08:00:44", "description": "Bafna Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. Despite this, the company’s stock has delivered exceptional returns over multiple time horizons, outperforming the Sensex by a wide margin. This article analyses the recent valuation changes, compares Bafna Pharma’s metrics with its peers, and assesses the implications for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 258.8 on Back of Strong Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2588-4125911", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_priceRelatedfactors_4125911.png", "date": "2026-07-29 10:39:32", "description": "From a 52-week low of Rs 77.01 to a fresh peak of Rs 258.8, Bafna Pharmaceuticals Ltd has surged an impressive 184.4% over the past year, significantly outperforming the Sensex which declined 4.58% during the same period. This remarkable rally culminated in the stock hitting its all-time high today, fuelled by a confluence of bullish technical indicators and sustained price momentum." } ], "total": 365, "sid": "852453", "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453" }, "announcements": [ { "details": "Bafna Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 13, 2019.", "source": "NSE", "caption": "Bafna Pharmaceuticals Limited - Outcome of Board Meeting", "datetime": "14-Nov-2019" }, { "details": " <table><tr><td>The Exchange had sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>", "source": "NSE", "caption": "Reply to Clarification- Financial results", "datetime": "27-Aug-2019" }, { "details": " <table><tr><td>BAFNAPHARM: Members of the Exchange are hereby informed that the trading in Equity Shares of Bafna Pharmaceuticals Limited shall be suspended w.e.f. August 26, 2019 (i.e. closing hours of trading on August 23, 2019) on account of Reduction of Share Capital. </td></tr></table>", "source": "NSE", "caption": "Suspension of trading in equity shares", "datetime": "21-Aug-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13", "dt": "2013-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Jul: New 52-week high at Rs.248.80

28 Jul: Further 52-week high at Rs.253.75

29 Jul: New 52-week high at Rs.258.80

30 Jul: 52-week high extended to Rs.263.95; valuation shifts noted

31 Jul: Week closes with new 52-week high at Rs.269.20

Week Open

Rs.245.00

W...

Read full news article

Bafna Pharmaceuticals Ltd is Rated Sell

2026-08-01 10:10:04

Bafna Pharmaceuticals Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's present position as of 01 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bafna Pharmaceuticals Ltd is Rated Sell

2026-08-01 10:10:04

Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 269.2

2026-07-31 10:36:44

Surging to a new 52-week high of Rs 269.2 on 31 Jul 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 205.94% gain over the past year against the Sensex’s 4.00% decline.

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 263.95

2026-07-30 10:36:13

Surging past its previous peaks, Bafna Pharmaceuticals Ltd touched a new 52-week high of Rs 263.95 on 30 Jul 2026, marking a remarkable rally of nearly 200% from its 52-week low of Rs 77.01. This milestone caps an eight-day winning streak that has propelled the stock well above all major moving averages, signalling robust price momentum and technical conviction.

Read full news article

Bafna Pharmaceuticals Ltd Valuation Shifts Amidst Strong Market Performance

2026-07-30 08:00:44

Bafna Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. Despite this, the company’s stock has delivered exceptional returns over multiple time horizons, outperforming the Sensex by a wide margin. This article analyses the recent valuation changes, compares Bafna Pharma’s metrics with its peers, and assesses the implications for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 258.8 on Back of Strong Technical Signals

2026-07-29 10:39:32

From a 52-week low of Rs 77.01 to a fresh peak of Rs 258.8, Bafna Pharmaceuticals Ltd has surged an impressive 184.4% over the past year, significantly outperforming the Sensex which declined 4.58% during the same period. This remarkable rally culminated in the stock hitting its all-time high today, fuelled by a confluence of bullish technical indicators and sustained price momentum.

Read full news article